Home › Asset managers › Aberdeen › 2023-2024 › Against the board
Two kinds of vote are listed: a board-sponsored proposal Aberdeen voted AGAINST or withheld on, and a shareholder proposal it voted FOR. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
1,455 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Aberdeen voted | Funds |
|---|---|---|---|---|---|---|
| TRAVELERS COMPANIES INC. | 2024-05-15 | Non-binding vote to approve executive compensation. | Say-on-Pay | Board | AGAINST | 3 |
| TREX COMPANY INC. | 2024-05-07 | Non-binding advisory vote on executive compensation ("say-on-pay"). | Say-on-Pay | Board | AGAINST | 3 |
| TWILIO INC. | 2024-06-06 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 3 |
| U.S. BANCORP | 2024-04-16 | An advisory vote to approve the compensation of our executives disclosed in the proxy statement. | Say-on-Pay | Board | AGAINST | 3 |
| UDR INC. | 2024-05-23 | Advisory vote to approve named executive officer compensation. | Say-on-Pay | Board | AGAINST | 3 |
| ULTRAGENYX PHARMACEUTICAL INC. | 2024-06-18 | Advisory (non-binding) vote to approve the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 3 |
| ULTRATECH CEMENT LTD. | 2023-08-11 | Reelect Rajashree Birla as Director | Director Elections | Board | AGAINST | 3 |
| UNITED AIRLINES HOLDINGS INC. | 2024-05-22 | A Vote to Approve, on a Nonbinding Advisory Basis, the Compensation of the Company's Named Executive Officers. | Say-on-Pay | Board | AGAINST | 3 |
| UNIVERSAL HEALTH REALTY INCOME TRUST | 2024-06-05 | Advisory (nonbinding) vote to approve named executive officer compensation. | Say-on-Pay | Board | AGAINST | 3 |
| VERISK ANALYTICS INC. | 2024-05-15 | To approve executive compensation on an advisory, non-binding basis. | Say-on-Pay | Board | AGAINST | 3 |
| VULCAN MATERIALS CO. | 2024-05-10 | Approval, on an advisory basis, of the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 3 |
| WALGREENS BOOTS ALLIANCE INC. | 2024-01-25 | Advisory vote to approve named executive officer compensation. | Say-on-Pay | Board | AGAINST | 3 |
| WARNER BROS. DISCOVERY INC. | 2024-06-03 | To vote on an advisory resolution to approve the 2023 compensation of Warner Bros. Discovery, Inc.'s named executive officers, commonly referred to as a "Say-on-Pay" vote. | Say-on-Pay | Board | AGAINST | 3 |
| WEC ENERGY GROUP INC. | 2024-05-09 | Advisory vote to approve executive compensation of the named executive officers | Say-on-Pay | Board | AGAINST | 3 |
| WELLTOWER INC. | 2024-05-23 | The ratification of the appointment of Ernst & Young LLP as Welltower Inc.'s independent registered public accounting firm for the year ending December 31, 2024. | Audit-related | Board | AGAINST | 3 |
| WEST PHARMACEUTICAL SERVICES INC. | 2024-04-23 | Election of Directors: Thomas W. Hofmann | Director Elections | Board | AGAINST | 3 |
| WEST PHARMACEUTICAL SERVICES INC. | 2024-04-23 | Ratification of the appointment of PricewaterhouseCoopers LLP ("PwC") as our independent registered public accounting firm for 2024; and | Audit-related | Board | AGAINST | 3 |
| WESTERN DIGITAL CORP. | 2023-11-15 | Approval on an advisory basis of the named executive officer compensation disclosed in the Proxy Statement. | Say-on-Pay | Board | AGAINST | 3 |
| WILLIAMS-SONOMA INC. | 2024-05-29 | An advisory vote to approve executive compensation | Say-on-Pay | Board | AGAINST | 3 |
| WILLIS TOWERS WATSON PUBLIC LIMITED CO. | 2024-05-22 | Approve, on an advisory basis, the named executive officer compensation. | Say-on-Pay | Board | AGAINST | 3 |
| WINTRUST FINANCIAL CORP. | 2024-05-23 | Proposal to approve, on an advisory (non-binding) basis, the Company's executive compensation as described in the 2024 Proxy Statement. | Say-on-Pay | Board | AGAINST | 3 |
| WYNN RESORTS LTD. | 2024-05-02 | To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement. | Say-on-Pay | Board | AGAINST | 3 |
| XCEL ENERGY INC. | 2024-05-22 | Approval of Xcel Energy Inc.'s executive compensation in an advisory vote (say on pay vote) | Say-on-Pay | Board | AGAINST | 3 |
| XYLEM INC. | 2024-05-16 | Advisory vote to approve the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 3 |
| YUM! BRANDS INC. | 2024-05-16 | Advisory Vote on Executive Compensation. | Say-on-Pay | Board | AGAINST | 3 |
| ZAI LAB LTD. | 2024-06-18 | THAT, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement, is hereby approved. | Say-on-Pay | Board | AGAINST | 3 |
| ZEBRA TECHNOLOGIES CORP. | 2024-05-09 | Advisory vote to approve Named Executive Officers' compensation. | Say-on-Pay | Board | AGAINST | 3 |
| ZIMMER BIOMET HOLDINGS INC. | 2024-05-10 | Election of Directors: Arthur J. Higgins | Director Elections | Board | AGAINST | 3 |
| ZIMMER BIOMET HOLDINGS INC. | 2024-05-10 | Election of Directors: Robert A. Hagemann | Director Elections | Board | AGAINST | 3 |
| ZIMMER BIOMET HOLDINGS INC. | 2024-05-10 | Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2024. | Audit-related | Board | AGAINST | 3 |
| 89BIO INC. | 2024-05-29 | Election of Directors: To be elected for terms expiring in 2027: Kathleen LaPorte | Director Elections | Board | ABSTAIN | 2 |
| ADAPTIVE BIOTECHNOLOGIES CORP. | 2024-06-07 | To elect two Class II director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2027 annual meeting of shareholders: Peter Neupert | Director Elections | Board | ABSTAIN | 2 |
| ADVANCED DRAINAGE SYSTEMS INC. | 2023-07-20 | Ratification of the appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for fiscal year 2024. | Audit-related | Board | AGAINST | 2 |
| AGILENT TECHNOLOGIES INC. | 2024-03-14 | To ratify the Audit and Finance Committee's appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm. | Audit-related | Board | AGAINST | 2 |
| AKERO THERAPEUTICS INC. | 2024-06-07 | Election of Class II Directors to serve until the 2027 annual meeting of stockholders and until his or her successor has been duly elected and qualified: Seth L. Harrison, M.D. | Director Elections | Board | ABSTAIN | 2 |
| ALEXANDRIA REAL ESTATE EQUITIES INC. | 2024-05-14 | Election of Directors: James P. Cain | Director Elections | Board | AGAINST | 2 |
| ALEXANDRIA REAL ESTATE EQUITIES INC. | 2024-05-14 | Election of Directors: Maria C. Freire | Director Elections | Board | AGAINST | 2 |
| ALEXANDRIA REAL ESTATE EQUITIES INC. | 2024-05-14 | Election of Directors: Michael A. Woronoff | Director Elections | Board | AGAINST | 2 |
| ALEXANDRIA REAL ESTATE EQUITIES INC. | 2024-05-14 | Election of Directors: Richard H. Klein | Director Elections | Board | AGAINST | 2 |
| ALEXANDRIA REAL ESTATE EQUITIES INC. | 2024-05-14 | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for the fiscal year ending December 31, 2024, as more particularly described in the accompanying Proxy Statement. | Audit-related | Board | AGAINST | 2 |
| ALGONQUIN POWER & UTILITIES CORP. | 2024-06-04 | Advisory Vote on Executive Compensation Approach | Compensation | Board | AGAINST | 2 |
| ALGONQUIN POWER & UTILITIES CORP. | 2024-06-04 | Amend Share Unit Plan | Compensation | Board | AGAINST | 2 |
| ALKERMES PLC | 2024-05-31 | To renew Board authority to disapply the statutory pre-emption rights that would otherwise apply under Irish law. | Capital Structure | Board | AGAINST | 2 |
| ALNYLAM PHARMACEUTICALS INC. | 2024-05-16 | To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam's independent auditors for the fiscal year ending December 31, 2024. | Audit-related | Board | AGAINST | 2 |
| ALPHATEC HOLDINGS INC. | 2024-06-12 | To elect nine persons to our Board of Directors; Mortimer Berkowitz III | Director Elections | Board | ABSTAIN | 2 |
| ALTAIR ENGINEERING INC. | 2024-05-16 | To vote, on an advisory basis, on the compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 2 |
| ALTIMMUNE INC. | 2023-09-28 | Hold an advisory vote on the compensation of the Company's named executive officers as disclosed in the attached Proxy Statement. | Say-on-Pay | Board | AGAINST | 2 |
| ALX ONCOLOGY HOLDINGS INC. | 2024-06-12 | Advisory vote to approve named executive officer compensation. | Say-on-Pay | Board | AGAINST | 2 |
| AMCOR PLC | 2023-11-08 | To approve, by non-binding, advisory vote, the Company's executive compensation. | Say-on-Pay | Board | AGAINST | 2 |
| AMERICAN ELECTRIC POWER COMPANY INC. | 2024-04-23 | Election of Directors: Linda A. Goodspeed | Director Elections | Board | AGAINST | 2 |
| AMERICAN WATER WORKS COMPANY INC. | 2024-05-15 | Election of Directors: Martha Clark Goss | Director Elections | Board | AGAINST | 2 |
| AMERICAN WATER WORKS COMPANY INC. | 2024-05-15 | Ratification of the appointment, by the Audit, Finance and Risk Committee of the Board of Directors, of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2024. | Audit-related | Board | AGAINST | 2 |
| AMICUS THERAPEUTICS INC. | 2024-06-06 | Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. | Audit-related | Board | AGAINST | 2 |
| APARTMENT INCOME REIT CORP. | 2023-09-15 | Advisory vote on executive compensation (Say on Pay). | Say-on-Pay | Board | AGAINST | 2 |
| APARTMENT INCOME REIT CORP. | 2024-06-25 | Proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to our principal executive officer, principal financial officer, and the three other most highly compensated executive officers calculated in accordance with the Securities and Exchange Commission's rules and regulations, that is based on or otherwise relates to the merger. | Say-on-Pay | Board | AGAINST | 2 |
| APARTMENT INVESTMENT AND MANAGEMENT CO. | 2023-09-29 | To conduct an advisory vote to approve executive compensation. | Say-on-Pay | Board | AGAINST | 2 |
| APARTMENT INVESTMENT AND MANAGEMENT CO. | 2024-06-28 | Advisory vote to approve executive compensation. | Say-on-Pay | Board | AGAINST | 2 |
| ARAMARK | 2024-01-30 | To hold a non-binding advisory vote on executive compensation. | Say-on-Pay | Board | AGAINST | 2 |
| ARCA BIOPHARMA INC. | 2024-01-30 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in this proxy statement. | Say-on-Pay | Board | AGAINST | 2 |
| ARCBEST CORP. | 2024-04-26 | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers. | Say-on-Pay | Board | AGAINST | 2 |
| ARCUTIS BIOTHERAPEUTICS INC. | 2024-06-14 | Election of Class I directors to hold office until the 2027 Annual Meeting of Stockholders or until their successors are elected: Terrie Curran | Director Elections | Board | ABSTAIN | 2 |
| ARDELYX INC. | 2024-06-14 | To approve the Amended and Restated 2014 Equity Incentive Award Plan; | Compensation | Board | AGAINST | 2 |
| ARDELYX INC. | 2024-06-14 | To elect two Class I directors to hold office until the 2027 Annual Meeting of Stockholders and until their successors are elected and qualified: Onaiza Cadoret-Manier | Director Elections | Board | ABSTAIN | 2 |
| ASCENDIS PHARMA A/S | 2024-05-30 | Approve Warrant Plan for Key Employees | Compensation | Board | AGAINST | 2 |
| ATLAS COPCO AB | 2024-04-24 | Approve Remuneration Report | Compensation | Board | AGAINST | 2 |
| ATLAS COPCO AB | 2024-04-24 | Reelect Anna Ohlsson-Leijon as Director | Director Elections | Board | AGAINST | 2 |
| ATLAS COPCO AB | 2024-04-24 | Reelect Hans Straberg as Board Chair | Director Elections | Board | AGAINST | 2 |
| ATLAS COPCO AB | 2024-04-24 | Reelect Johan Forssell as Director | Director Elections | Board | AGAINST | 2 |
| ATLAS COPCO AB | 2024-04-24 | Reelect Peter Wallenberg Jr as Director | Director Elections | Board | AGAINST | 2 |
| AUTOLIV INC. | 2024-05-10 | Advisory Vote on Autoliv, Inc.'s 2023 Executive Compensation | Say-on-Pay | Board | AGAINST | 2 |
| AVALONBAY COMMUNITIES INC. | 2024-05-16 | To ratify the selection of Ernst & Young LLP as the Company's independent auditors for the year ending December 31, 2024. | Audit-related | Board | AGAINST | 2 |
| AVANGRID INC. | 2023-07-18 | APPROVE, ON AN ADVISORY BASIS, NAMED EXECUTIVE OFFICER COMPENSATION. | Say-on-Pay | Board | AGAINST | 2 |
| AZEK COMPANY INC. | 2024-03-01 | To approve, on an advisory, non-binding basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 2 |
| B3 SA-BRASIL, BOLSA, BALCAO | 2024-04-25 | Approve Remuneration of Company's Management | Compensation | Board | ABSTAIN | 2 |
| BANNER CORP. | 2024-05-22 | Advisory approval of the compensation of Banner Corporation's named executive officers | Say-on-Pay | Board | AGAINST | 2 |
| BEIGENE LTD. | 2024-06-05 | Ordinary Resolution THAT, on a non-binding, advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, be and is hereby approved. | Say-on-Pay | Board | AGAINST | 2 |
| BEIGENE LTD. | 2024-06-05 | Resolution 10 - Ordinary Resolution THAT the Company and its underwriters be and are hereby authorized, in their sole discretion, to allocate to Amgen Inc. ("Amgen"), up to a maximum amount of shares in order to maintain the same shareholding percentage of Amgen (based on the then-outstanding share capital of the Company) before and after the allocation of the corresponding securities issued pursuant to an offering conducted pursuant to the general mandate set forth in Resolution 7 for a period of five years, which period will be subject to an extension on a rolling basis each year. | Capital Structure | Board | AGAINST | 2 |
| BEIGENE LTD. | 2024-06-05 | Resolution 11 - Ordinary Resolution THAT the grant of restricted share units ("RSUs") with a grant date fair value of US$6,000,000 to Mr. John V. Oyler under the Second Amended and Restated 2016 Share Option and Incentive Plan (as amended, the "2016 Plan"), according to the terms and conditions described in the Proxy Statement, be and is hereby approved. | Compensation | Board | AGAINST | 2 |
| BEIGENE LTD. | 2024-06-05 | Resolution 13 - Ordinary Resolution THAT the grant of RSUs with a grant date fair value of US$1,333,333 to Dr. Xiaodong Wang under the 2016 Plan, according to the terms and conditions described in the Proxy Statement, be and is hereby approved. | Compensation | Board | AGAINST | 2 |
| BEIGENE LTD. | 2024-06-05 | Resolution 14 - Ordinary Resolution THAT the grant of RSUs with a grant date fair value of US$200,000 to each of the independent non-executive directors, Dr. Olivier Brandicourt, Dr. Margaret Dugan, Mr. Donald W. Glazer, Mr. Michael Goller, Mr. Anthony C. Hooper, Mr. Ranjeev Krishana, Dr. Alessandro Riva, Dr. Corazon (Corsee) D. Sanders, and Mr. Qingqing Yi, under the 2016 Plan, according to the terms and conditions described in the Proxy Statement, be and is hereby approved. | Compensation | Board | AGAINST | 2 |
| BEIGENE LTD. | 2024-06-05 | Resolution 17(a) - Ordinary Resolution THAT the Third Amended and Restated 2016 Share Option and Incentive Plan of the Company, as described in the Proxy Statement, be and is hereby approved. | Compensation | Board | AGAINST | 2 |
| BEIGENE LTD. | 2024-06-05 | Resolution 2 - Ordinary Resolution THAT Donald W. Glazer be and is hereby re-elected to serve as a Class II director of the Company until the 2027 annual general meeting of shareholders and until his successor is duly elected and qualified, subject to his earlier resignation or removal. | Director Elections | Board | AGAINST | 2 |
| BEIGENE LTD. | 2024-06-05 | Resolution 7 - Ordinary Resolution THAT the granting of a share issue mandate to the Board of Directors to issue, allot or deal with unissued ordinary shares and/or American Depositary Shares ("ADSs") (including any sale or transfer of treasury shares (which shall have the meaning ascribed to it under the HK Listing Rules coming into effect on June 11, 2024) out of treasury) not exceeding 20% of the total number of issued shares of the Company (excluding treasury shares) as of the date of passing of this ordinary resolution up to the next annual general meeting of shareholders of the Company be and is hereby approved. | Capital Structure | Board | AGAINST | 2 |
| BEIGENE LTD. | 2024-06-05 | Resolution 9 - Ordinary Resolution THAT the Company and its underwriters be and are hereby authorized, in their sole discretion, to allocate to each of Baker Bros. Advisors LP and Hillhouse Capital Management, Ltd. and parties affiliated with each of them (the "Existing Shareholders"), up to a maximum amount of shares in order to maintain the same shareholding percentage of each of the Existing Shareholders (based on the then-outstanding share capital of the Company) before and after the allocation of the corresponding securities issued pursuant to an offering conducted pursuant to the general mandate set forth in Resolution 7 for a period of five years, which period will be subject to an extension on a rolling basis each year. | Capital Structure | Board | AGAINST | 2 |
| BILL HOLDINGS INC. | 2023-12-07 | To approve, on an advisory basis, the compensation of our Named Executive Officers (Say-on-Pay). | Say-on-Pay | Board | AGAINST | 2 |
| BIOMARIN PHARMACEUTICAL INC. | 2024-05-21 | Election of Directors: Elaine J. Heron | Director Elections | Board | ABSTAIN | 2 |
| BIOMARIN PHARMACEUTICAL INC. | 2024-05-21 | Election of Directors: Richard A. Meier | Director Elections | Board | ABSTAIN | 2 |
| BIOMARIN PHARMACEUTICAL INC. | 2024-05-21 | To ratify the selection of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2024. | Audit-related | Board | AGAINST | 2 |
| BIONTECH SE | 2024-05-17 | Approve Issuance of Warrants/Bonds with Warrants Attached/Convertible Bonds without Preemptive Rights up to Aggregate Nominal Amount of EUR 3 Billion; Approve Creation of EUR 24.9 Million Pool of Capital to Guarantee Conversion Rights | Capital Structure | Board | AGAINST | 2 |
| BIONTECH SE | 2024-05-17 | Approve Remuneration Policy for the Management Board | Compensation | Board | AGAINST | 2 |
| BIONTECH SE | 2024-05-17 | Approve Remuneration Policy for the Supervisory Board | Compensation | Board | AGAINST | 2 |
| BIONTECH SE | 2024-05-17 | Approve Remuneration Report | Compensation | Board | AGAINST | 2 |
| BOSTON PROPERTIES INC. | 2024-05-22 | Election of Directors: Carol B. Einiger | Director Elections | Board | AGAINST | 2 |
| BOSTON PROPERTIES INC. | 2024-05-22 | To ratify the Audit Committee's appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. | Audit-related | Board | AGAINST | 2 |
| BRIDGEBIO PHARMA INC. | 2024-06-21 | To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to, among other things, increase the number of shares of common stock reserved for issuance thereunder by 6,500,000 shares. | Compensation | Board | AGAINST | 2 |
| BURLINGTON STORES INC. | 2024-05-22 | Approval, on a non-binding advisory basis, of the compensation of Burlington Stores, Inc.'s named executive officers | Say-on-Pay | Board | AGAINST | 2 |
| CARLYLE GROUP INC. | 2024-05-29 | Non-Binding Vote to Approve Named Executive Officer Compensation ("Say-on-Pay") | Say-on-Pay | Board | AGAINST | 2 |
| CIGNA GROUP | 2024-04-24 | Election of Directors: Donna F. Zarcone | Director Elections | Board | AGAINST | 2 |
| CIGNA GROUP | 2024-04-24 | Election of Directors: Eric C. Wiseman | Director Elections | Board | AGAINST | 2 |
| CIGNA GROUP | 2024-04-24 | Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group's independent registered public accounting firm for 2024. | Audit-related | Board | AGAINST | 2 |
← Previous Page 8 of 15 Next →
← Back to Aberdeen 2023-2024 overview
Built 2026-10-04 from SEC Form N-PX filings.